biotech
18 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Rescooped by Arsalan Arif from BiotechRegulation
Scoop.it!

Kaua’i goes rogue, anti-GMO bill passed over mayor’s veto, contentious legal fight imminent | Genetic Literacy Project

Kaua’i goes rogue, anti-GMO bill passed over mayor’s veto, contentious legal fight imminent | Genetic Literacy Project | biotech | Scoop.it
Kaua'i appears headed for an ugly legal battle as political maneuvering by anti-GMO forces led to the selection of a hand-picked candidate, who voted to overturn the mayor's veto of a controversial bill designed to fatally wound crop biotechnology...

Via Erik Janus
Arsalan Arif's insight:

this is my insight. its great.

more...
No comment yet.
Scooped by Arsalan Arif
Scoop.it!

The Sky is Falling for Personal Genomics! Oh, nevermind. It’s just a cease & desist letter from the FDA to 23andMe.

The Sky is Falling for Personal Genomics! Oh, nevermind. It’s just a cease & desist letter from the FDA to 23andMe. | biotech | Scoop.it
Easily the most useful thing that's yet been written about FDA vs @23andMe: sober analysis from GLR: http://t.co/musalxU2X5
more...
No comment yet.
Scooped by Arsalan Arif
Scoop.it!

The unfinished internal market for medical devices

The unfinished internal market for medical devices | biotech | Scoop.it
The EU market for medical devices is not fully harmonized, which means that you cannot rely on a medical device being a medical device everywhere in the EU. That, essentially, is what the European ...
more...
No comment yet.
Rescooped by Arsalan Arif from Stem Cells & Tissue Engineering
Scoop.it!

Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies


Via Jacob Blumenthal
more...
Jacob Blumenthal's curator insight, November 13, 2013 9:28 AM

This new review, summarizes the current status of stem cell-based therapies. 

To learn about stem cells and related cell therapies, please enter:

http://discovery.lifemapsc.com/stem-cell-differentiation/in-vitro-cells

 

*Cell therapies cards are currently a premium feature

 

Scooped by Arsalan Arif
Scoop.it!

Pfizer To Expand Clinical Trial Data Access, Takes Step Toward Transparency ... - Medical Daily

Pfizer Inc. updated its clinical trial data access policy yesterday, and will soon begin to share data and results with study participants.

more...
No comment yet.
Scooped by Arsalan Arif
Scoop.it!

New study explains why promising dementia drugs failed in clinical trials | PsyPost

New study explains why promising dementia drugs failed in clinical trials | PsyPost | biotech | Scoop.it
Alzheimer's disease is the most common cause of dementia among older people, yet there currently are no effective drugs to stop, slow or prevent disease progression.
more...
No comment yet.
Scooped by Arsalan Arif
Scoop.it!

23andMe Founder Vows To Cooperate With FDA, Addresses Customer Concerns

23andMe Founder Vows To Cooperate With FDA, Addresses Customer Concerns | biotech | Scoop.it
This evening Anne Wojcicki CEO and founder of Google-backed genetic testing company 23andMe vowed to cooperate with the FDA which ordered the company...
more...
No comment yet.
Scooped by Arsalan Arif
Scoop.it!

NYC Launches $100M Life Science Fund

NYC Launches $100M Life Science Fund | biotech | Scoop.it
NYC's Deputy has announced that the city is launching the New York City Emerging Life Science Technology Investment Fund (Fantastic: NYC Launches $100M Life Science Fund w/ @celgene @LillyPad and @generalelectric http://t.co/kTx1X9m29W)...
more...
No comment yet.
Rescooped by Arsalan Arif from UX-UI-Wearable-Tech for Enhanced Human
Scoop.it!

FDA clears Android-based continuous ECG monitor

FDA clears Android-based continuous ECG monitor | biotech | Scoop.it

Via Olivier Janin
more...
No comment yet.